Q BioMed
Financial ratios & Valuation

Historical Multiples (2013 – 2022)

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 TTM Median
Valuation Ratios
Price/Earnings ratio
-8.33K-256.51-29.62-4.23-3.23-2.88-2.04-1.76-1.38-0.34-0.09-3.23
Price/Sales ratio
N/AN/AN/AN/AN/AN/AN/A812.5461.912.511.66N/A
Price/Book Value ratio
170.06852.42-125.79-14.87131.91-253.32-4.76-22.66-2.58-0.15-0.08-0.08
Price/Cash Flow ratio
N/A-261.31-352.22-19.66-8.41-4.15-5.86-3.91-2.810.36-0.27-8.41
Price/Free Cash Flow ratio
N/A-261.31-352.22-19.66-8.41-3.85-5.86-3.91-2.810.36-0.27-8.41
Price/Earnings Growth ratio
N/A-0.09-0.01-0.00-0.040.05-0.120.080.020.00-0.00-0.04
Dividend Yield
N/AN/AN/AN/AN/AN/AN/A1.53%4.13%N/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/AN/AN/A-986.69%-26.20%-3.16%20.57%N/A
Operating Profit Margin
N/AN/AN/AN/AN/AN/AN/A-43818.04%-3777.44%-1211.74%-1195.06%N/A
Pretax Profit Margin
N/AN/AN/AN/AN/AN/AN/A-44973.97%-4213.02%-721.67%-1705.17%N/A
Net Profit Margin
N/AN/AN/AN/AN/AN/AN/A-45961.35%-4472.19%-721.67%-1705.27%N/A
Effective Tax Rate
N/AN/A86.28%81.79%-5.22%-2.70%-14.20%-2.19%-6.15%N/AN/A-5.22%
Return on Assets
-2%-300.81%-826.90%-488.28%-1757.76%-289.99%-1833.53%-2211.50%-1080.62%-58.37%-1289.95%-1757.76%
Return On Equity
-2.04%-332.31%424.61%351.00%-4081.94%8768.51%232.69%1282.06%186.69%44.44%103.45%-4081.94%
Return on Capital Employed
-2.04%-332.31%372.06%350.32%-3472.83%-325.90%174.42%1222.28%157.69%74.62%62.23%-3472.83%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.02N/A
Quick Ratio
5010.540.330.441.756.280.030.130.070.000.016.28
Cash ratio
5010.540.330.441.756.250.030.100.060.000.016.25
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/AN/A149.4614.8011.17N/A
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/AN/AN/A32.90N/A27.66N/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/AN/A182.3714.8030.41N/A
Days of Payables Outstanding
N/A11.50N/AN/AN/AN/A4.75K808.061.98K2.65K2.53KN/A
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/A-808.06-1.80K-2.63K-2.51KN/A
Debt Ratios
Debt Ratio
N/AN/A4.501.85N/A0.895.760.143.771.1615.5215.52
Debt Equity Ratio
N/AN/A-2.31-1.33N/A-27.17-0.73-0.08-0.65-0.89-1.06-27.17
Long-term Debt to Capitalization
N/AN/A7.38-0.12N/A1.03-0.09N/AN/AN/AN/A1.03
Total Debt to Capitalization
N/AN/A1.763.98N/A1.03-2.72-0.09-1.87-8.09N/A1.03
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-3.26N/A
Cash Flow to Debt Ratio
N/AN/A-0.15-0.56N/A-2.24-1.11-67.61-1.400.47N/AN/A
Company Equity Multiplier
1.021.10-0.51-0.712.32-30.23-0.12-0.57-0.17-0.76-0.06-0.06
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/AN/AN/AN/A-207.78-21.996.82-6.06N/A
Free Cash Flow / Operating Cash Flow Ratio
N/A11111.071110.9911.07
Cash Flow Coverage Ratio
N/AN/A-0.15-0.56N/A-2.24-1.11-67.61-1.400.47N/AN/A
Short Term Coverage Ratio
N/AN/A-0.30-0.61N/AN/A-1.26-67.61-1.400.47-0.60N/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/A-2.72%-5.72%N/AN/AN/A